Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Xavier Frapaise"'
Autor:
Ralph Laufer, Philippe Drevot, Michaël Hocquemiller, Bérangère Deleglise, Marie Deneux, Karen Pignet-Aiach, Xavier Frapaise
Publikováno v:
Molecular Genetics and Metabolism. 135:S71-S72
Autor:
Francois-Xavier Frapaise
Publikováno v:
Molecular Genetics and Metabolism. 135:S44
Autor:
Francois-Xavier Frapaise
Publikováno v:
BioDrugs. 32:319-324
Most patients still have limited or no access to life-changing therapeutic proteins in the treatment of their cancer or autoimmune disorders. The current clinical development model of biosimilars is expensive, and in most cases, large, phase 3 trials
Autor:
Francois-Xavier Frapaise
Publikováno v:
Biodrugs
Autor:
F Xavier Frapaise, M Michel Samama, Jawed Fareed, Jeanine M. Walenga, Walter Jeske, Rodger L. Bick
Publikováno v:
Expert opinion on investigational drugs. 11(3)
Fondaparinux (Arixtra, Sanofi-Synthélabo/Organon) is the first of a new class of antithrombotic agents distinct from low molecular weight heparins (LMWHs) and heparin. It is a chemically synthetic pentasaccharide mimicking the site of heparin that b